Cervical cancer experts campaign to increase screening rates and save lives

April 30, 2025
Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening

A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …

Novo Nordisk Foundation expands ambitious Challenge Programme internationally 

April 30, 2025
Research and Development Challenge Programme, Denmark, Novo Nordisk, Pharmacy, international

The Novo Nordisk Foundation Challenge Programme, a leading open competition grant programme, invites researchers outside of Denmark to participate and …

Gifthealth appoints Chip Parkinson as CEO to lead next phase of growth

April 29, 2025
Business Services, Pharmaceutical Consultancy Services CEO, Gifthealth, Pharmacy, pharmacy care

Gifthealth, a technology-driven pharmacy care company, has appointed Chip Parkinson as its new chief executive officer. The move marks a …

Ryan Smith appointed as global head of sales at Astoriom

April 29, 2025
Logistics & Distribution, Research and Development Astoriom, Pharmacy, appointment, sample storage solutions

Global R&D sample stability and biorepository storage company, Astoriom, has announced the appointment of Ryan Smith as global head of …

europe-1395916_640

EU approval granted for rare kidney disease treatment

April 29, 2025
Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology

The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …

stethoscope_and_background_doctor

Study finds new test could better predict risk of heart disease

April 28, 2025
Research and Development Cardiology, Chalmers University of Technologyu, Harvard, cholesterol tests, cvd

A study by Harvard University, US, and Chalmers University of Technology, Sweden, has found that measuring a lipoprotein marker combination …

blood-75301_640

Sobi and Sanofi’s Foundation S renew partnership with World Federation of Hemophilia

April 28, 2025
Pharmacy sales & educational programmes, Sales and Marketing Haematology, Sanofi, World Federation of Hemophilia, bleeding disorder, sobi

Sobi and Sanofi, through its organisation Foundation S, have extended their partnership with the World Federation of Hemophilia (WFH) Humanitarian …

McDavid Stilwell appointed as CFO of CPTx

April 28, 2025
Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics

CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …

Pharma supply chain event LogiPharma celebrates another successful year

April 28, 2025
Industry Associations, Medical Communications Cold Chain Technologies, DB Schenker, LogiPharma, Pharmacy, PluumoPlus, supply chain event, supply chain professionals

In Lyon, France, over 2,200 life sciences supply chain professionals gathered for LogiPharma 2025, a leading conference dedicated to supply …

clinical_trials

Successful clinical outcomes for drug treating rare stroke condition

April 25, 2025
Research and Development Bioxodes, Neurology, clinical trial, stroke

Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral …

trialy

Mosaic Therapeutics in-licenses clinical oncology programmes from Astex Pharma

April 25, 2025
Clinical Trial Services, Industry Associations, Mergers and Acquisitions, Research and Development Astex pharmaceuticals, Mosaic Therapeutics, Oncology, clinical trial

Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug …

Philippe Masset appointed to Vect-Horus board of directors

April 25, 2025
Research and Development Oncology, Vect-Horus, appointment, board of directors, imaging agents

Vect-Horus has announced the appointment of Philippe Masset to the company’s board of directors. This contributes to a series of …

blood_tests_pic

Mursla Bio’s platform for surveillance of liver cancer receives FDA approval

April 24, 2025
Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …

Hansa Biopharma appoints Renée Aguiar-Lucander as CEO

April 24, 2025
Research and Development CEO, Corporate, Hansa Biopharma, appointment, immunology

Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Renée Aguiar-Lucander, replacing Søren Tulstrup …

Neurizon makes appointments to executive team

April 24, 2025
Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases

Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …

ViroCell and UCL launch trial to treat childhood leukaemia relapse

April 24, 2025
Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …

Dual immunotherapy for bowel cancer now available under NHS

April 23, 2025
Research and Development Bristol Myer Squibb, MHRA, NICE, Oncology, bowel cancer, colorectal cancer, immunotherapy

Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in the UK by the Medicines …

CARBOGEN AMCIS manufacturing license advances services in China

April 23, 2025
Manufacturing Services, Manufacturing and Production Carbogen Amcis, China, Corporate, Drug Manufacturing License (DML), Shanghai, manufacturing

Swiss pharma manufacturing company, CARBOGEN AMCIS, has announced that its facility in Shanghai, China, has been successfully granted Drug Manufacturing …

handshake_2

AOTI diabetic foot care therapy to be used by NHS

April 23, 2025
Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study

Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …

Galapagos announces leadership changes amid planned company split

April 22, 2025
Analytical & Laboratory Services, Research and Development CEO Appointment, Corporate, Galapagos, cell therapy

Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been …

The Gateway to Local Adoption Series

Latest content